Waveguide
WaveGuide Corporation develops the WaveGuide Formµla™, the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, serving pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators with on-site chemical and biological diagnostics.
- Company typePrivate
- Founded2015
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Waveguide does
WaveGuide Corporation is a Waltham, Massachusetts-based medical and industrial diagnostic device company founded in 2015 by Dr. Marcus Semones around portable nuclear magnetic resonance technology licensed exclusively from Harvard University. The company's flagship product, the WaveGuide Formµla™, is marketed as the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, bringing laboratory-grade NMR analytical sensitivity and specificity to field environments without requiring PhD operators, fixed infrastructure, or large sample volumes. The platform combines proprietary magnetic nanoparticles for selective analyte binding with embedded WiFi and cellular connectivity (enabled by an AT&T partnership announced in 2018) for real-time data transmission.
The device is deployed across pharmaceutical quality control (anti-counterfeit screening, biosimilar authentication, stability studies, vaccine potency), medical diagnostics (tuberculosis and ovarian cancer screening under active FDA 510(k) pathways), food and beverage authenticity testing (dairy, olive oil, lubricants), and industrial fluid and equipment health monitoring. WaveGuide offers GMP and 21 CFR Part 11 compliant configurations, holds ISO 13485:2016 medical device manufacturer certification, and lists FDA certifications FM-672330 and MD-687233 (both running into 2027). The company has demonstrated quantifiable outcomes including TB detection at ~90% overall accuracy in sputum, contaminant detection in cough syrup at 2.5% concentration, and antibody concentration variation detection below 2 mg/mL.
WaveGuide sells exclusively through a direct enterprise sales motion (no self-serve or channel partners), reaching pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators via website contact, phone ((617) 892-9700), and email ([email protected]). The company has raised over $30 million cumulatively across multiple SEC exempt securities offerings between 2015 and 2025, and operates with a lean leadership team of seven senior individuals plus a six-person board of directors and a scientific and advisory board.
Waveguide firmographics
Firmographics- Name
- Waveguide
- Legal name
- WaveGuide Corporation
- Website
- https://waveguidecorp.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- WaveGuide Corporation develops the WaveGuide Formµla™, the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument, serving pharmaceutical manufacturers, medical facilities, food safety inspectors, and industrial operators with on-site chemical and biological diagnostics.
- Ownership category
- akta.pro rank
Waveguide industry classification
Industry- Product category
- Analytical Instrumentation & Diagnostic Devices
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)
Keywords
Where Waveguide is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Waveguide business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Others, Marketing or Sales, Infrastructure
Revenue model
- Portable NMR Hardware Sales: WaveGuide sells its WaveGuide Formµla™ portable NMR device as a hardware product to enterprise customers across pharma, medical, food safety, and industrial sectors. Device configurations include GMP and 21 CFR Part 11 compliance variants.
- Customizable App Licensing / Software: The WaveGuide Formµla™ platform supports multiple customizable apps for specific testing applications (purity, potency, authenticity). Apps can be tailored to specific industries and use cases (pharmaceuticals, food, oil & gas, medical diagnostics), suggesting a software/app licensing or configurable module model atop the hardware platform.
- Professional Services & Regulatory Support: Wendy Graham-Coco, COO, oversees clinical, regulatory, and quality systems operations, and the company maintains ISO 13485:2016 medical device manufacturer certification. The company supports FDA 510(k) pathways for tuberculosis and ovarian cancer screening diagnostics, suggesting revenue from regulatory consulting and certification-related professional services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise direct sale — pricing available upon inquiry |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Waveguide product offering
Product offeringCore offering
WaveGuide Corporation develops, manufactures and sells the WaveGuide Formµla™ — the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. The device enables on-site chemical and biological analysis without laboratory infrastructure, using proprietary magnetic nanoparticles to detect and quantify target analytes for medical diagnostics, pharmaceutical quality control, food safety, and industrial fluid monitoring. The platform supports configurable apps for purity, potency, authenticity, pathogen, and oncology testing, with available GMP and 21 CFR Part 11 compliance configurations for regulated environments.
Product overview
WaveGuide Corporation offers a single unified product—the WaveGuide Formµla™—the world's first battery-powered portable micro-nuclear magnetic resonance (μNMR) device. This compact analytical instrument brings laboratory-grade NMR spectroscopy to the field, enabling on-site detection and quantification of substances for medical diagnostics, pharmaceutical quality control, food safety testing, and industrial applications. The device requires no special training, operates on battery power, and includes embedded WiFi and cellular connectivity with a secure cloud-based environment for data tracking and analysis.
Differentiator
Problem solved
Functional benefit
Brands
- WaveGuide Formµla™: The world's first portable battery-operated NMR device that detects and quantifies substances for medical, material and diagnostic applications.
Products and services
- WaveGuide Formµla™ Portable μNMR Instrument The world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. Detects and quantifies substances for medical diagnostics (TB, ovarian cancer, pathogens), pharmaceutical quality control (anti-counterfeit, biosimilars authentication, vaccine potency, stability studies), food safety (purity, authenticity, fat/oil/moisture) and industrial maintenance (lubricant quality, wear monitoring). Operates on battery power with embedded WiFi/cellular connectivity for real-time cloud data transmission. Supports configurable apps by sample type and includes GMP and 21 CFR Part 11 compliant configurations. Requires only micro-liter samples and no specialized training; delivers results in minutes.
Quantifiable outcome
- TB detection with ~90% overall accuracy and ~85% sample accuracy, with detection in 1–3 hours in sputum using the WaveGuide Formµla™ prototype
- +4 more outcomes
Companies that use Waveguide
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Waveguide technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature6 records
Waveguide partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- AT&TcoreAT&T provides global cellular connectivity for the WaveGuide Formµla™ portable NMR device, enabling real-time secure data transmission from deployed field devices back to the company for analysis and outbreak tracking. The partnership was featured at Mobile World Congress 2018 (#MWC18) where AT&T Business showcased the WaveGuide device to a global audience. AT&T's Business news and Cheddar News have covered WaveGuide, providing significant third-party marketing credibility.
- Harvard University (Technology Licensing Office)coreWaveGuide secured an exclusive license from the Technology Licensing Office of Harvard University for the portable NMR technology across multiple fields of use including medical diagnostics, pharmaceutical, food, oil & gas, THC/cannabis, and roadside detection. The underlying scientific breakthrough was pioneered by founder Dr. Marcus Semones during his faculty appointment at Harvard University's Physics Department. This exclusive license is the foundational IP moat for the entire WaveGuide business.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Waveguide competitors and assessment
Company assessmentDirect peers
- Nanalysis: Nanalysis manufactures benchtop 60 MHz NMR spectrometers (NMReady series) for industrial QC, academic, and teaching use. It is the closest direct competitor in compact NMR form factor and serves overlapping pharma and chemistry end markets.
- Magritek: Magritek develops compact benchtop TD-NMR and NMR systems (Spinsolve family) used for chemistry education, reaction monitoring, and industrial QC. It competes directly with WaveGuide in the portable/benchtop TD-NMR category.
- Oxford Instruments (Magnetic Resonance): Oxford Instruments' MQC series of benchtop TD-NMR analyzers is widely used in food, agriculture, and industrial fluid analysis — overlapping heavily with WaveGuide's industrial and food-safety verticals in a portable form factor.
Emerging players
- T2 Biosystems: T2 Biosystems applies magnetic resonance (T2MR) to rapid in-vitro diagnostics for sepsis and other infectious diseases. It uses MR as a diagnostic platform like WaveGuide, though in a centralized instrument format rather than portable.
- bioMérieux (BioFire): bioMérieux's BioFire business delivers rapid molecular diagnostics (FilmArray panels) for infectious disease at the point of care. It overlaps with WaveGuide's TB and infectious-disease field-diagnostic ambitions, albeit with a different (PCR) underlying technology.
Broad incumbents
- Bruker Corporation: Bruker is the global leader in high-field NMR instrumentation and also offers benchtop/personal NMR (incl. former PicoSpin). It is the dominant incumbent WaveGuide must displace in pharma QC and academic NMR markets.
- JEOL: JEOL manufactures NMR spectrometers across high-field and benchtop segments (JNM-ECZ series) used in pharma, chemistry, and materials research. It is a broad incumbent in laboratory NMR alongside Bruker.
- Thermo Fisher Scientific: Thermo Fisher is the largest analytical instruments and life-sciences tools company, offering benchtop NMR, handheld spectroscopy (via Ahura Scientific acquisition), pharma QC, and clinical diagnostics platforms that overlap with multiple WaveGuide verticals.
- Agilent Technologies: Agilent provides a broad portfolio of analytical instruments (NMR, FTIR, mass spec) and pharma/biopharma QC solutions. It competes in the same regulated QC workflows WaveGuide targets, though typically with lab-bound instruments.
Others
- MKS Instruments (Precisive): MKS acquired Precisive, a developer of compact gas-phase optical analyzers for oil & gas and industrial process monitoring. It is an adjacent, portable-analytical-instrument peer with overlap in industrial fluid and process analysis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Waveguide social profiles
Digital presenceWaveguide compliance and trust
Trust signalCompliance5 records
Waveguide financial estimates
Financial estimateRevenue estimate
Valuation estimate
Waveguide leadership team
Management profileNumber of profiles
Profiles7 records
Waveguide funding detail
Funding detailFunding overview
Funding rounds9 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Waveguide M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Waveguide
What does Waveguide do?
WaveGuide Corporation develops, manufactures and sells the WaveGuide Formµla™ — the world's first battery-operated portable micro-nuclear magnetic resonance (μNMR) instrument. The device enables on-site chemical and biological analysis without laboratory infrastructure, using proprietary magnetic nanoparticles to detect and quantify target analytes for medical diagnostics, pharmaceutical quality control, food safety, and industrial fluid monitoring. The platform supports configurable apps for purity, potency, authenticity, pathogen, and oncology testing, with available GMP and 21 CFR Part 11 compliance configurations for regulated environments.
Is Waveguide a public or private company?
Waveguide is a private company. It is classified as venture growth investor backed and is currently operating.
When was Waveguide founded?
Waveguide was founded in 2015. It employs 1 to 10 people.
Where is Waveguide based?
Waveguide is headquartered in Cambridge, United States, in the North America region.
How does Waveguide make money?
Three revenue lines are on record. Portable NMR Hardware Sales are the primary driver. The others are customizable App Licensing / Software and professional Services & Regulatory Support.
Who are Waveguide's main competitors?
Direct peers on record are Nanalysis, Magritek and Oxford Instruments (Magnetic Resonance). Emerging players are T2 Biosystems and bioMérieux (BioFire). Broad incumbents are Bruker Corporation, JEOL, Thermo Fisher Scientific and Agilent Technologies. MKS Instruments (Precisive) is listed as an others.
Does Waveguide have an API?
No public API is recorded for Waveguide.
What industry is Waveguide in?
Waveguide's product category is Analytical Instrumentation & Diagnostic Devices. Its primary akta.pro industry code is HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS). Its NAICS code is 334516 and its SIC code is 3826.